117 related articles for article (PubMed ID: 16923918)
1. Retroviral E-DNA: persistence and gene expression in nondividing immune cells.
Cara A; Klotman ME
J Leukoc Biol; 2006 Nov; 80(5):1013-7. PubMed ID: 16923918
[TBL] [Abstract][Full Text] [Related]
2. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.
Goff SP
J Gene Med; 2001; 3(6):517-28. PubMed ID: 11778899
[TBL] [Abstract][Full Text] [Related]
3. New insight on the role of extrachromosomal retroviral DNA.
Cara A; Reitz MS
Leukemia; 1997 Sep; 11(9):1395-9. PubMed ID: 9305590
[TBL] [Abstract][Full Text] [Related]
4. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
5. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
6. The drug monosodium luminol (GVT) preserves crypt-villus epithelial organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus.
Scofield VL; Yan M; Kuang X; Kim SJ; Wong PK
Immunol Lett; 2009 Feb; 122(2):150-8. PubMed ID: 19186189
[TBL] [Abstract][Full Text] [Related]
7. Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses.
Smith JA; Daniel R
ACS Chem Biol; 2006 May; 1(4):217-26. PubMed ID: 17163676
[TBL] [Abstract][Full Text] [Related]
8. Restriction of retroviral infection of macrophages.
Sharkey M
Curr Top Microbiol Immunol; 2013; 371():105-22. PubMed ID: 23686233
[TBL] [Abstract][Full Text] [Related]
9. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of the infectivity of the proviral DNA of a retrovirus in vitro: Evaluation of methods for DNA inactivation.
Sheng-Fowler L; Lewis AM; Peden K
Biologicals; 2009 Aug; 37(4):259-69. PubMed ID: 19457682
[TBL] [Abstract][Full Text] [Related]
11. Macrophages and residual HIV infection.
Crowe SM
Curr Opin HIV AIDS; 2006 Mar; 1(2):129-33. PubMed ID: 19372796
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of HIV.
Trono D
Clin Lab Med; 1994 Jun; 14(2):203-20. PubMed ID: 7924188
[TBL] [Abstract][Full Text] [Related]
13. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
[TBL] [Abstract][Full Text] [Related]
14. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
[TBL] [Abstract][Full Text] [Related]
16. Retroviruses and autoimmunity.
Sekigawa I; Ogasawara H; Kaneko H; Hishikawa T; Hashimoto H
Intern Med; 2001 Feb; 40(2):80-6. PubMed ID: 11300167
[TBL] [Abstract][Full Text] [Related]
17. The ups and downs of gene expression and retroviral DNA integration.
Engelman A
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1275-6. PubMed ID: 15677323
[No Abstract] [Full Text] [Related]
18. [Regulation of retroviral replication and pathogenesis by host factors].
Miyazawa M
Uirusu; 2002 Jun; 52(1):69-76. PubMed ID: 12227182
[No Abstract] [Full Text] [Related]
19. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
20. Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy.
Gros L; Pelegrin M; Plays M; Piechaczyk M
J Virol; 2006 Oct; 80(20):10191-200. PubMed ID: 17005696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
